MC 2494

CAS No. ——

MC 2494( MC2494 )

Catalog No. M17073 CAS No. ——

MC 2494 is a nove potent, pan-Sirtuin (SirT) inhibitor.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    MC 2494
  • Note
    Research use only, not for human use.
  • Brief Description
    MC 2494 is a nove potent, pan-Sirtuin (SirT) inhibitor.
  • Description
    MC 2494 is a nove potent, pan-Sirtuin (SirT) inhibitor, increases RIP1 acetylation in the death domain and induces bona fide tumour-restricted acetylated RIP1/caspase-8-mediated apoptosis; displays tumour-selective potential in vitro, in leukemic blasts ex vivo, and in vivo in both xenograft and allograft cancer models; also displays tumour-preventive activity by blocking DMBA-induced mammary gland hyper-proliferation in vivo.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    MC2494
  • Pathway
    Chromatin/Epigenetic
  • Target
    Sirtuin
  • Recptor
    Sirtuin
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    ——
  • Formula Weight
    426.86
  • Molecular Formula
    C24H15ClN4O2
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    ——
  • Chemical Name
    (E)-3-(4-(2-chlorobenzoyl)-1H-pyrrol-2-yl)-2-cyano-N-(quinolin-5-yl)acrylamide

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Altucci L, et al. Clin Cancer Res. 2018 Mar 13. pii: clincanres.3081.2017.
molnova catalog
related products
  • SIRT2-IN-9

    SIRT2-IN-9 is a selective SRIT2 inhibitor with an IC50 value of 1.3 μM.SIRT2-IN-9 inhibits the proliferation of MCF-7 breast cancer cells.SIRT2-IN-9 can be used for cancer research.

  • SRT 1460

    SRT1460 is a potent, selective SIRT1 activator with EC1.5 of 2.9 uM.

  • YK-3-237

    A novel small molecule sirtuin-1 (SIRT1) activator that reduces acetylation of mutant 53 and exhibits anti-proliferative effects against TNBC cells carrying mutant p53.